An antifungal drug, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete''s foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. Such drugs are usually obtained by a doctor''s prescription, but a few are available OTC (over-the-counter).
Asia Pacific is expected to be the fastest growing regional segment for the antifungal drug market in 2017 within the forecast period due to the rapid spread of fungal infection in this region. Asia Pacific accounted as a leading market of the global antifungal drug market in 2015 in terms of growth.
In 2019, the market size of Antifungal Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antifungal Drugs.
This report studies the global market size of Antifungal Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antifungal Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Asperqillus
Alternaria
Abbott Laboratories
Pfizer
GlaxoSmithKline
Bayer Healthcare
Novartis
Sanofi-Aventis
Merck
Kramer Laboratories
Enzon Pharmaceuticals
Gilead
Market Segment by Product Type
Clotrimazole.
Econazole.
Miconazole.
Terbinafine.
Fluconazole.
Ketoconazole.
Amphotericin.
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antifungal Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antifungal Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antifungal Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Asia Pacific is expected to be the fastest growing regional segment for the antifungal drug market in 2017 within the forecast period due to the rapid spread of fungal infection in this region. Asia Pacific accounted as a leading market of the global antifungal drug market in 2015 in terms of growth.
In 2019, the market size of Antifungal Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antifungal Drugs.
This report studies the global market size of Antifungal Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antifungal Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Asperqillus
Alternaria
Abbott Laboratories
Pfizer
GlaxoSmithKline
Bayer Healthcare
Novartis
Sanofi-Aventis
Merck
Kramer Laboratories
Enzon Pharmaceuticals
Gilead
Market Segment by Product Type
Clotrimazole.
Econazole.
Miconazole.
Terbinafine.
Fluconazole.
Ketoconazole.
Amphotericin.
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antifungal Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antifungal Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antifungal Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antifungal Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Clotrimazole.
1.3.3 Econazole.
1.3.4 Miconazole.
1.3.5 Terbinafine.
1.3.6 Fluconazole.
1.3.7 Ketoconazole.
1.3.8 Amphotericin.
1.4 Market Segment by Application
1.4.1 Global Antifungal Drugs Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antifungal Drugs Market Size
2.1.1 Global Antifungal Drugs Revenue 2014-2025
2.1.2 Global Antifungal Drugs Sales 2014-2025
2.2 Antifungal Drugs Growth Rate by Regions
2.2.1 Global Antifungal Drugs Sales by Regions 2014-2019
2.2.2 Global Antifungal Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antifungal Drugs Sales by Manufacturers
3.1.1 Antifungal Drugs Sales by Manufacturers 2014-2019
3.1.2 Antifungal Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Antifungal Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Antifungal Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antifungal Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Antifungal Drugs Price by Manufacturers
3.4 Key Manufacturers Antifungal Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antifungal Drugs Market
3.6 Key Manufacturers Antifungal Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Clotrimazole. Sales and Revenue (2014-2019)
4.1.2 Econazole. Sales and Revenue (2014-2019)
4.1.3 Miconazole. Sales and Revenue (2014-2019)
4.1.4 Terbinafine. Sales and Revenue (2014-2019)
4.1.5 Fluconazole. Sales and Revenue (2014-2019)
4.1.6 Ketoconazole. Sales and Revenue (2014-2019)
4.1.7 Amphotericin. Sales and Revenue (2014-2019)
4.2 Global Antifungal Drugs Sales Market Share by Type
4.3 Global Antifungal Drugs Revenue Market Share by Type
4.4 Antifungal Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antifungal Drugs Sales by Application
6 United States
6.1 United States Antifungal Drugs Breakdown Data by Company
6.2 United States Antifungal Drugs Breakdown Data by Type
6.3 United States Antifungal Drugs Breakdown Data by Application
7 European Union
7.1 European Union Antifungal Drugs Breakdown Data by Company
7.2 European Union Antifungal Drugs Breakdown Data by Type
7.3 European Union Antifungal Drugs Breakdown Data by Application
8 China
8.1 China Antifungal Drugs Breakdown Data by Company
8.2 China Antifungal Drugs Breakdown Data by Type
8.3 China Antifungal Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antifungal Drugs Breakdown Data by Company
9.2 Rest of World Antifungal Drugs Breakdown Data by Type
9.3 Rest of World Antifungal Drugs Breakdown Data by Application
9.4 Rest of World Antifungal Drugs Breakdown Data by Countries
9.4.1 Rest of World Antifungal Drugs Sales by Countries
9.4.2 Rest of World Antifungal Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Asperqillus
10.1.1 Asperqillus Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antifungal Drugs
10.1.4 Antifungal Drugs Product Introduction
10.1.5 Asperqillus Recent Development
10.2 Alternaria
10.2.1 Alternaria Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antifungal Drugs
10.2.4 Antifungal Drugs Product Introduction
10.2.5 Alternaria Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antifungal Drugs
10.3.4 Antifungal Drugs Product Introduction
10.3.5 Abbott Laboratories Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antifungal Drugs
10.4.4 Antifungal Drugs Product Introduction
10.4.5 Pfizer Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antifungal Drugs
10.5.4 Antifungal Drugs Product Introduction
10.5.5 GlaxoSmithKline Recent Development
10.6 Bayer Healthcare
10.6.1 Bayer Healthcare Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antifungal Drugs
10.6.4 Antifungal Drugs Product Introduction
10.6.5 Bayer Healthcare Recent Development
10.7 Novartis
10.7.1 Novartis Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antifungal Drugs
10.7.4 Antifungal Drugs Product Introduction
10.7.5 Novartis Recent Development
10.8 Sanofi-Aventis
10.8.1 Sanofi-Aventis Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Antifungal Drugs
10.8.4 Antifungal Drugs Product Introduction
10.8.5 Sanofi-Aventis Recent Development
10.9 Merck
10.9.1 Merck Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Antifungal Drugs
10.9.4 Antifungal Drugs Product Introduction
10.9.5 Merck Recent Development
10.10 Kramer Laboratories
10.10.1 Kramer Laboratories Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Antifungal Drugs
10.10.4 Antifungal Drugs Product Introduction
10.10.5 Kramer Laboratories Recent Development
10.11 Enzon Pharmaceuticals
10.12 Gilead
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antifungal Drugs Sales Channels
11.2.2 Antifungal Drugs Distributors
11.3 Antifungal Drugs Customers
12 Market Forecast
12.1 Global Antifungal Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Antifungal Drugs Sales Forecast by Type
12.3 Global Antifungal Drugs Sales Forecast by Application
12.4 Antifungal Drugs Forecast by Regions
12.4.1 Global Antifungal Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Antifungal Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antifungal Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Clotrimazole.
1.3.3 Econazole.
1.3.4 Miconazole.
1.3.5 Terbinafine.
1.3.6 Fluconazole.
1.3.7 Ketoconazole.
1.3.8 Amphotericin.
1.4 Market Segment by Application
1.4.1 Global Antifungal Drugs Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antifungal Drugs Market Size
2.1.1 Global Antifungal Drugs Revenue 2014-2025
2.1.2 Global Antifungal Drugs Sales 2014-2025
2.2 Antifungal Drugs Growth Rate by Regions
2.2.1 Global Antifungal Drugs Sales by Regions 2014-2019
2.2.2 Global Antifungal Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antifungal Drugs Sales by Manufacturers
3.1.1 Antifungal Drugs Sales by Manufacturers 2014-2019
3.1.2 Antifungal Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Antifungal Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Antifungal Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antifungal Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Antifungal Drugs Price by Manufacturers
3.4 Key Manufacturers Antifungal Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antifungal Drugs Market
3.6 Key Manufacturers Antifungal Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Clotrimazole. Sales and Revenue (2014-2019)
4.1.2 Econazole. Sales and Revenue (2014-2019)
4.1.3 Miconazole. Sales and Revenue (2014-2019)
4.1.4 Terbinafine. Sales and Revenue (2014-2019)
4.1.5 Fluconazole. Sales and Revenue (2014-2019)
4.1.6 Ketoconazole. Sales and Revenue (2014-2019)
4.1.7 Amphotericin. Sales and Revenue (2014-2019)
4.2 Global Antifungal Drugs Sales Market Share by Type
4.3 Global Antifungal Drugs Revenue Market Share by Type
4.4 Antifungal Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antifungal Drugs Sales by Application
6 United States
6.1 United States Antifungal Drugs Breakdown Data by Company
6.2 United States Antifungal Drugs Breakdown Data by Type
6.3 United States Antifungal Drugs Breakdown Data by Application
7 European Union
7.1 European Union Antifungal Drugs Breakdown Data by Company
7.2 European Union Antifungal Drugs Breakdown Data by Type
7.3 European Union Antifungal Drugs Breakdown Data by Application
8 China
8.1 China Antifungal Drugs Breakdown Data by Company
8.2 China Antifungal Drugs Breakdown Data by Type
8.3 China Antifungal Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antifungal Drugs Breakdown Data by Company
9.2 Rest of World Antifungal Drugs Breakdown Data by Type
9.3 Rest of World Antifungal Drugs Breakdown Data by Application
9.4 Rest of World Antifungal Drugs Breakdown Data by Countries
9.4.1 Rest of World Antifungal Drugs Sales by Countries
9.4.2 Rest of World Antifungal Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Asperqillus
10.1.1 Asperqillus Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antifungal Drugs
10.1.4 Antifungal Drugs Product Introduction
10.1.5 Asperqillus Recent Development
10.2 Alternaria
10.2.1 Alternaria Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antifungal Drugs
10.2.4 Antifungal Drugs Product Introduction
10.2.5 Alternaria Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antifungal Drugs
10.3.4 Antifungal Drugs Product Introduction
10.3.5 Abbott Laboratories Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antifungal Drugs
10.4.4 Antifungal Drugs Product Introduction
10.4.5 Pfizer Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antifungal Drugs
10.5.4 Antifungal Drugs Product Introduction
10.5.5 GlaxoSmithKline Recent Development
10.6 Bayer Healthcare
10.6.1 Bayer Healthcare Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antifungal Drugs
10.6.4 Antifungal Drugs Product Introduction
10.6.5 Bayer Healthcare Recent Development
10.7 Novartis
10.7.1 Novartis Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antifungal Drugs
10.7.4 Antifungal Drugs Product Introduction
10.7.5 Novartis Recent Development
10.8 Sanofi-Aventis
10.8.1 Sanofi-Aventis Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Antifungal Drugs
10.8.4 Antifungal Drugs Product Introduction
10.8.5 Sanofi-Aventis Recent Development
10.9 Merck
10.9.1 Merck Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Antifungal Drugs
10.9.4 Antifungal Drugs Product Introduction
10.9.5 Merck Recent Development
10.10 Kramer Laboratories
10.10.1 Kramer Laboratories Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Antifungal Drugs
10.10.4 Antifungal Drugs Product Introduction
10.10.5 Kramer Laboratories Recent Development
10.11 Enzon Pharmaceuticals
10.12 Gilead
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antifungal Drugs Sales Channels
11.2.2 Antifungal Drugs Distributors
11.3 Antifungal Drugs Customers
12 Market Forecast
12.1 Global Antifungal Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Antifungal Drugs Sales Forecast by Type
12.3 Global Antifungal Drugs Sales Forecast by Application
12.4 Antifungal Drugs Forecast by Regions
12.4.1 Global Antifungal Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Antifungal Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
